#Neumora_Therapeutics
Neumora Therapeutics Faces Shareholder Scrutiny Following Major Trial Failures#United_States#New_York#Neumora_Therapeutics#NMRA#SueWallSt
Neumora Therapeutics Faces Shareholder Scrutiny Following Major Trial Failures
Neumora Therapeutics has come under investigation after failing key Phase 3 trials for navacaprant, leading to significant shareholder losses.
third-news.com
June 17, 2026 at 2:25 PM
Kuehn Law Investigates Neumora Therapeutics Shareholder Concerns: A Call to Action#USA#New_York#Kuehn_Law#Investor_Alert#Neumora_Therapeutics
Kuehn Law Investigates Neumora Therapeutics Shareholder Concerns: A Call to Action
Kuehn Law is urging Neumora Therapeutics investors to reach out amid serious allegations of fiduciary duty breaches by company executives.
third-news.com
May 14, 2025 at 7:54 PM
Levi & Korsinsky Alerts Neumora Investors of Class Action Lawsuit Deadline Approaching in April 2025#United_States#New_York#Class_Action#Levi_Korsinsky#Neumora_Therapeutics
Levi & Korsinsky Alerts Neumora Investors of Class Action Lawsuit Deadline Approaching in April 2025
Levi & Korsinsky announces important news for Neumora Therapeutics investors regarding a class action lawsuit with a deadline coming up soon in April 2025.
third-news.com
April 4, 2025 at 9:58 AM
Kessler Topaz Meltzer & Check Encourages Investors of Neumora Therapeutics Amid Class Action Lawsuit#USA#Kessler_Topaz#Securities_Fraud#Radnor#Neumora_Therapeutics
Kessler Topaz Meltzer & Check Encourages Investors of Neumora Therapeutics Amid Class Action Lawsuit
Kessler Topaz Meltzer & Check, LLP has initiated a class action lawsuit for Neumora Therapeutics, urging shareholders with losses to engage for potential recovery.
third-news.com
April 3, 2025 at 5:35 AM
Important Information for Neumora Therapeutics Shareholders Regarding Upcoming Lead Plaintiff Deadline#United_States#New_York#Gross_Law_Firm#Neumora_Therapeutics#NMRA
Important Information for Neumora Therapeutics Shareholders Regarding Upcoming Lead Plaintiff Deadline
Shareholders of Neumora Therapeutics, Inc. need to be aware of the April 7, 2025 lead plaintiff deadline in a significant lawsuit. Immediate action is required.
third-news.com
March 27, 2025 at 9:50 AM
Investors of Neumora Therapeutics Urged to Participate in Ongoing Securities Class Action Lawsuit#United_States#New_York#Rosen_Law_Firm#Neumora_Therapeutics#NMRA_Investors
Investors of Neumora Therapeutics Urged to Participate in Ongoing Securities Class Action Lawsuit
Rosen Law Firm calls upon Neumora Therapeutics' stockholders to engage in a securities class action ahead of an important deadline for lead plaintiffs.
third-news.com
March 26, 2025 at 7:52 AM
Neumora Therapeutics, Inc. Faces Class Action Lawsuit with Key Deadline Approaching in April 2025#USA#New_York#Gross_Law_Firm#Neumora_Therapeutics#NMRA
Neumora Therapeutics, Inc. Faces Class Action Lawsuit with Key Deadline Approaching in April 2025
Investors in Neumora Therapeutics, Inc. are reminded of an upcoming class action lawsuit deadline on April 7, 2025. Those affected are encouraged to act.
third-news.com
March 24, 2025 at 10:03 AM
Levi & Korsinsky Alerts Neumora Therapeutics Investors of Class Action Lawsuit Progress and Important Deadline#United_States#New_York#Levi_&_Korsinsky#Neumora_Therapeutics#NMRA
Levi & Korsinsky Alerts Neumora Therapeutics Investors of Class Action Lawsuit Progress and Important Deadline
Levi & Korsinsky LLP has informed Neumora Therapeutics investors of a pending class action lawsuit. Investors have until April 7, 2025, to act.
third-news.com
March 21, 2025 at 9:57 AM
Neumora Therapeutics Faces Lawsuit Over Alleged Securities Violations: Important Deadline Approaches for Shareholders#United_States#New_York#Gross_Law_Firm#Neumora_Therapeutics#NMRA
Neumora Therapeutics Faces Lawsuit Over Alleged Securities Violations: Important Deadline Approaches for Shareholders
Neumora Therapeutics, Inc. is facing a lawsuit related to securities law violations. Shareholders are urged to contact The Gross Law Firm before April 7, 2025 to learn about their rights.
third-news.com
March 20, 2025 at 9:14 AM
Neumora Therapeutics Faces Legal Action Over SEC Violations: Investor Rights at Stake#United_States#New_York#Levi_Korsinsky#SEC#Neumora_Therapeutics
Neumora Therapeutics Faces Legal Action Over SEC Violations: Investor Rights at Stake
Neumora Therapeutics, Inc. is embroiled in a class action lawsuit concerning alleged securities law violations. Investors should take note of their rights.
third-news.com
March 18, 2025 at 10:00 AM
Pomerantz Law Firm Issues Reminder for Neumora Therapeutics Investors Amid Class Action Lawsuit and Key Dates#United_States#New_York#Pomerantz_Law_Firm#Neumora_Therapeutics#NMRA
Pomerantz Law Firm Issues Reminder for Neumora Therapeutics Investors Amid Class Action Lawsuit and Key Dates
Pomerantz Law Firm alerts investors of a class action lawsuit against Neumora Therapeutics. Key deadlines and necessary actions detailed for affected investors.
third-news.com
March 17, 2025 at 4:53 PM